Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Biogen Inc.
Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.
IPO Date: January 3, 1994
Sector: Healthcare
Industry: Biotech
Market Cap: $17.72B
Activated in VL: True
Average Daily Range
Avg Daily Range: $2.47 | 1.32%
Avg Daily Range (30 D): $2.44 | 2.00%
Avg Daily Range (90 D): $2.03 | 1.52%
Institutional Daily Volume
Avg Daily Volume: 2.09M
Avg Daily Volume (30 D): 1.3M
Avg Daily Volume (90 D): 1.24M
Trade Size
Avg Trade Size (Sh.): 109
Avg Trade Size (Sh.) (30 D): 40
Avg Trade Size (Sh.) (90 D): 40
Institutional Trades
Total Inst.Trades: 44,001
Avg Inst. Trade: $5.96M
Avg Inst. Trade (30 D): $12.09M
Avg Inst. Trade (90 D): $11.8M
Avg Inst. Trade Volume: .04M
Avg Inst. Trades (Per Day): 8
Market Closing Trades
Avg Closing Trade: $27.72M
Avg Closing Trade (30 D): $34.77M
Avg Closing Trade (90 D): $36.22M
Avg Closing Volume: 132.29K
       
News
May 8, 2025 @ 2:00 PM
Medisafe PATHWAYS, Eisai and Biogen Recognized for...
Source: N/A
May 1, 2025 @ 6:46 PM
Biogen Beats Q1 Earnings Expectations As Two Newco...
Source: Vandana Singh
Apr 15, 2025 @ 11:00 PM
Leqembi®∇ (lecanemab) is the First Medici...
Source: N/A
Apr 10, 2025 @ 5:58 PM
Specialists Set Sights on CLE Pipeline as Unmet Ne...
Source: Spherix Global Insights
Apr 10, 2025 @ 9:59 AM
Biopharmaceuticals Global Overview Report 2025: Gl...
Source: Researchandmarkets.Com
Financials
  TTM Q1 2025 Q3 2024
Basic EPS $1.65 $2.67
Diluted EPS $1.64 $2.66
Revenue $ $ 2.43B $ 2.47B
Gross Profit $ $ 1.8B $ 1.83B
Net Income / Loss $ $ 240.5M $ 388.5M
Operating Income / Loss $ $ 311.2M $ 451M
Cost of Revenue $ $ 629.3M $ 638.7M
Net Cash Flow $ $ 223.3M $ -209.7M
PE Ratio    
Splits
Jan 18, 2001:   1:3